Cassava Sciences, Inc.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US14817C1071
USD
1.36
-0.08 (-5.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Cassava Sciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-90.00
-24.00
-97.00
-76.00
-32.00
-6.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
38.00
-1.00
9.00
-4.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-32.00
-116.00
-82.00
-77.00
-30.00
-5.00
Cash Flow from Investing Activities
0.00
0.00
0.00
-2.00
-22.00
0.00
Cash Flow from Financing Activities
0.00
124.00
2.00
47.00
192.00
75.00
Net Cash Inflow / Outflow
-33.00
7.00
-79.00
-32.00
139.00
70.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cassava Sciences, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-90.973
-198.36
108.00
54.14%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
38.203
-2.261
40.00
1789.65%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-32.252
-157.692
125.00
79.55%
Cash Flow from Investing Activities
-0.581
74.876
-74.00
-100.78%
Cash Flow from Financing Activities
-0.239
49.196
-49.00
-100.49%
Net Cash Inflow / Outflow
-33.072
-33.62
0.00
1.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 72.42% vs -42.55% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-32.25
-116.93
72.42%